Asia Islet Biology and Incretin Research Association (AIBIS) 2024
トラベルグラント 千葉 幸輝先生
{ 300件 }
Asia Islet Biology and Incretin Research Association (AIBIS) 2024
トラベルグラント 千葉 幸輝先生
MRCR Top Reviewer Award 2023 藤枝 雄一郎先生
Tsuneta S, Suno K, Fujieda Y, Watanabe M, Watanabe S, Hirata K, Nagai T, Kudo K.
Accumulation of Technetium-99m Tetrofosmin on Myocardial Perfusion Scintigraphy in a Patient With Immunoglobulin G4-Related Coronary Periarteritis Canadian Journal of Cardiology, in press
IF:6.2
Ueda Y, Nakazawa D, Nishio S, Shiratori-Aso S, Kudo T, Miyoshi-Harashima A, Watanabe-Kusunoki K, Hattanda F, Iwasaki S, Tsuji T, Tomaru U, Aratani Y, Yamamoto M, Ishizu A, Atsumi T.
Nrf2 activation regulates NETosis, endothelial injury, and renal disease in myeloperoxidase-positive antineutrophil cytoplasmic antibody-associated vasculitis.
Kidney International, in press.
IF：19.6
Kanako Watanabe-Kusunoki, and Hans-Joachim Anders.
Balancing efficacy and safety of complement inhibitors.
Journal of Autoimmunity, in press
IF: 12.8
Sho Furusawa, Hiroshi Nomoto, Chiho Oba-Yamamoto, Jun Takeuchi, Miki Ito, Hiroyoshi Kurihara, Shin Aoki, Aika Miya, Hiraku Kameda, Akinobu Nakamura, and Tatsuya Atsumi Real-world clinical evidence of oral semaglutide on metabolic abnormalities in subjects with type 2 diabetes: a multicenter retrospective observational study (the Sapporo-Oral SEMA study) ENDOCRINE JOURNAL, in press
IF: 2.0
Aika Miya, Akinobu Nakamura, Yuka Suzuki, Hiroshi Nomoto, Hiraku Kameda, Kyu Yong Cho, Tatsuya Atsumi Frequency and Determinants of Lipid Management Target Achievement in Primary Prevention of Cardiovascular Disease in Type 2 Diabetes Diabetology International, in press.
IF: 2.2
Mizui M, Kono M. Novel therapeutic strategies targeting abnormal T-cell signaling in systemic lupus erythematosus.
Clin Immunol. in press.
IF：8.6
日本糖尿病・肥満動物学会 研究賞 中村 昭伸先生
2024年度日本リウマチ学会 奨励賞 久田 諒先生